Search research articles
Contact Us
Filters
Showing results (371-380 of 417) with videos related to
Page
of 42
Sort By:
Cancer Research
|
December 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Yaohua Yang, Lang Wu, Xiang Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Isabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Plos Medicine
|
August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Yan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Human Molecular Genetics
|
November 8, 2014
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Jodie N Painter, Tracy A O'Mara, Jyotsna Batra, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Communications Biology
|
January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer risk
Joe Dennis, Jonathan P Tyrer, Logan C Walker, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 417) with videos related to
Sort By:
Page
of 42
Cancer Research
|
December 19, 2018
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk
Yaohua Yang, Lang Wu, Xiang Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Isabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Plos Medicine
|
August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Yan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Virchows Archiv : an International Journal of Pathology
|
November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Eun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Cancer Causes & Control : CCC
|
April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Human Molecular Genetics
|
November 8, 2014
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Jodie N Painter, Tracy A O'Mara, Jyotsna Batra, et al.
The Journal of Pathology. Clinical Research
|
March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel, Eun-Young Kang, Ashley Weir, et al.
Communications Biology
|
January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer risk
Joe Dennis, Jonathan P Tyrer, Logan C Walker, et al.
Page
of 42